February 12, 2013 | JLL Partners, a private equity firm, announced yesterday that two of its subsidiaries have commenced a tender offer for all outstanding shares of BioClinica at a price of $7.25 per share in cash. A successful offer will result in a merger between BioClinica and BioCore Holdings, one of the subsidiaries. The Board of Directors of BioClinica has unanimously approved and declared advisable the merger agreement. Press Release